HDAC inhibitors, such as trichostatin A (TSA), valproic acid (VPA), suberoylanilide hydroxamicacid (SAHA), MS-275, and benzamide (chidamide), have become a new class of drugs in cancer therapy [5]. The gene discussed is HDAC9; the disease is cancer.